The principal differences in tumor growth pattern – papillary versus follicular – is intriguing and cannot easily be attributed to the differential pathogenicity of mutant RAS and BRAF of which both confer constitutive activation of the MAPK signaling pathway. The gene discussed is BRAF; the disease is neoplasm.